Physician profile
Anand Kumar
NPI 1649535915
$7,595.20
in general payments reported to CMS, 2019-2025
8 companies · $3,147 in 2025
The $3,147 reported for 2025 was more than what 87% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $75.00 · 2024: $4,373 · 2025: $3,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,396 · Food and Beverage: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,396.26 |
| Food and Beverage | $1,198.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $5,298.12 | 2024-2025 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655, Olympus |
| Ovesco Endoscopy USA, INC. | $1,081.40 | 2024 | |
| Boston Scientific Corporation | $853.27 | 2024-2025 | Resolution 360 Clip, Axios |
| Fujifilm Healthcare Americas Corporation | $160.00 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $92.45 | 2024-2025 | Bridion |
| Olympus America INC. | $72.04 | 2025 | Visiglide |
| Micro-Tech Endoscopy USA, INC. | $23.47 | 2025 | Lockado |
| Janssen Biotech, INC. | $14.45 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anand Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.